发明申请
US20090069314A1 Hydroxyalkyl Substituted Imidazoquinoline Compounds and Methods
失效
羟烷基取代的咪唑并喹啉化合物和方法
- 专利标题： Hydroxyalkyl Substituted Imidazoquinoline Compounds and Methods
- 专利标题（中）： 羟烷基取代的咪唑并喹啉化合物和方法
-
申请号： US11885006申请日： 2006-02-22
-
公开(公告)号： US20090069314A1公开(公告)日： 2009-03-12
- 发明人: Tushar A. Kshirsagar , Bryon A. Merrill , Shri Niwas , Gregory D. Lundquist, JR. , Philip D. Heppner , Michael E. Danielson
- 申请人： Tushar A. Kshirsagar , Bryon A. Merrill , Shri Niwas , Gregory D. Lundquist, JR. , Philip D. Heppner , Michael E. Danielson
- 申请人地址： US MA Wellesley
- 专利权人： Coley Pharmaceutical Group, Inc.
- 当前专利权人： Coley Pharmaceutical Group, Inc.
- 当前专利权人地址： US MA Wellesley
- 国际申请： PCT/US06/06042 WO 20060222
- 主分类号： A61K31/5377
- IPC分类号： A61K31/5377 ; C07D471/04 ; A61K31/437 ; A61K31/496 ; A61P31/12 ; A61P35/00 ; C07D401/14 ; C07D413/14
摘要：
Certain imidazoquinolines with a hydroxymethyl or hydroxyethyl substituent at the 2-position, and an aryl or heteroaryl substituent at the 7-position, pharmaceutical compositions containing the compounds, intermediates, methods of making and methods of use of these compounds as immunomodulators, for preferentially inducing IFN-α biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases are disclosed.
公开/授权文献
信息查询
IPC分类:
